3/31
04:05 pm
fbio
Fortress Biotech Reports 2024 Financial Results and Recent Corporate Highlights
Low
Report
Fortress Biotech Reports 2024 Financial Results and Recent Corporate Highlights
3/17
08:55 am
fbio
Partex and Fortress Biotech Announce Strategic Collaboration to Accelerate Asset Identification and Evaluation Using Proprietary AI Platform
Low
Report
Partex and Fortress Biotech Announce Strategic Collaboration to Accelerate Asset Identification and Evaluation Using Proprietary AI Platform
3/11
10:55 am
fbio
Fortress Biotech, Inc. (NASDAQ: FBIO) had its "buy" rating re-affirmed by analysts at Roth Mkm. They now have a $16.00 price target on the stock, up previously from $15.00.
Low
Report
Fortress Biotech, Inc. (NASDAQ: FBIO) had its "buy" rating re-affirmed by analysts at Roth Mkm. They now have a $16.00 price target on the stock, up previously from $15.00.
3/10
07:47 am
fbio
Sun Pharma agrees to acquire Checkpoint Therapeutics [Yahoo! Finance]
Medium
Report
Sun Pharma agrees to acquire Checkpoint Therapeutics [Yahoo! Finance]
1/27
08:30 am
fbio
Fortress Biotech Announces First Patient Dosed in Phase 2 Clinical Trial of Triplex Vaccination in Stem Cell Donors to Reduce CMV Events in Recipients of HSCT
Low
Report
Fortress Biotech Announces First Patient Dosed in Phase 2 Clinical Trial of Triplex Vaccination in Stem Cell Donors to Reduce CMV Events in Recipients of HSCT